Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands.

Maartje S JacobsJeroen F SchoutenPieter T de BoerMikael HoffmannLars-Åke LevinMaarten Jacobus Postma

Published in: Current medical research and opinion (2018)

This study demonstrated that secondary adherence was high in this specific setting among patients with at least two initial dispensations of a NOAC covering a minimum of 180 days. The use of NOACs in a once daily regimen showed higher adherence compared to a twice daily regimen.

Keyphrases

oral anticoagulants
atrial fibrillation
physical activity
glycemic control
type diabetes
skeletal muscle
weight loss